Insights

Strategic Focus Emerging biotech startup with a novel HIV approach (eCD4-Ig) and in vivo protection data, presenting a potential collaboration or licensing opportunity for advanced therapeutics development and preclinical validation services.

Clinical and Regulatory Readiness Early-stage company with proof-of-concept in non-human primates, indicating potential needs for translational research, regulatory consulting, and IND-enabling studies to advance toward human trials.

Funding and Growth Potential Revenue in the low millions range suggests a lean operation likely seeking partnerships, grant support, and strategic investors to scale manufacturing, clinical development, and distribution capabilities.

Technical Stack Fit Shareable technology footprint and digital tooling (WordPress, Google Workspace, charting, code libraries) indicate openness to collaborations that leverage data platforms, lab informatics, or digital marketing/sponsorship partnerships.

Market Positioning Unique HIV entry-blocking strategy positions Emmune as a potential partner for large biopharma exploring novel prevention and treatment modalities, offering opportunities for co-development, licensing, or joint venture discussions.

Similar companies to Emmune, Inc.

Emmune, Inc. Tech Stack

Emmune, Inc. uses 8 technology products and services including WordPress, Google Workspace, Chart.js, and more. Explore Emmune, Inc.'s tech stack below.

  • Content Management System
  • Chart.js
    Javascript Graphics
  • imagesLoaded
    Javascript Libraries
  • Lua
    Programming Languages
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • GoDaddy
    Web Hosting

Emmune, Inc.'s Email Address Formats

Emmune, Inc. uses at least 2 email formats:
Emmune, Inc. Email FormatsExamplePercentage
FLast@emmune.bioJDoe@emmune.bio
73%
Last@emmune.bioDoe@emmune.bio
27%

Frequently Asked Questions

What is Emmune, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Emmune, Inc.'s official website is emmune.bio and has social profiles on LinkedIn.

How much revenue does Emmune, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, Emmune, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Emmune, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Emmune, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Emmune, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, Emmune, Inc. has approximately 5 employees across 1 continents, including North America. Key team members include Director Of In Vivo Pharmacology: K. C. Explore Emmune, Inc.'s employee directory with LeadIQ.

What industry does Emmune, Inc. belong to?

Minus sign iconPlus sign icon
Emmune, Inc. operates in the Biotechnology Research industry.

What technology does Emmune, Inc. use?

Minus sign iconPlus sign icon
Emmune, Inc.'s tech stack includes WordPress, Google Workspace, Chart.js, imagesLoaded, Lua, PHP, X-Content-Type-Options and GoDaddy.

What is Emmune, Inc.'s email format?

Minus sign iconPlus sign icon
Emmune, Inc.'s email format typically follows the pattern of FLast@emmune.bio. Find more Emmune, Inc. email formats with LeadIQ.
Emmune, Inc. logo

Emmune, Inc.

Biotechnology ResearchMassachusetts, United States2-10 Employees

Emmune, Inc. is a biotechnology research company based in Cambridge, Massachusetts. The firm focuses on strategies to treat and prevent HIV infection, leveraging a synthetic antibody built from the virus receptors CD4 and CCR5 to recognize all HIV-1 isolates. In preclinical contexts, a single intramuscular dose delivering this construct via an adeno-associated virus vector has shown protective effects in monkey models against multiple live-virus challenges. The company operates in a small team within the biotechnology sector, developing approaches that aim to address HIV transmission and infection through receptor-based targeting. Located in the Cambridge area, Emmune positions itself within the biomedical research community pursuing novel preventive and therapeutic solutions for HIV.

Section iconCompany Overview

Website
emmune.bio
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Emmune, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.